Chenpeng Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chenpeng Zheng has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Caihui Hu
Department of Ultrasound Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents’ Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Municipal Health Commission Key Laboratory of Children’s Vital Organ Development and Diseases, Chongqing 400014, China
2 shared publications - Jingyu Chen
Department of Ultrasound Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Diseases Ministry of Education Key Laboratory of Child Development and Disorders Chongqing China
2 shared publications - Yang Gao
Department of Ultrasound Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents’ Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Municipal Health Commission Key Laboratory of Children’s Vital Organ Development and Diseases, Chongqing 400014, China
2 shared publications - Yi Tang
Department of Ultrasonography, Children’s Hospital of Chongqing Medical University, Chongqing, China
2 shared publications - Fazhi Zhou
Department of Ultrasound, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
1 shared publication - Fenglin Xu
Department of Ultrasound, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
1 shared publication
Latest Publications
- Open Access
- 13 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (4) , 571
Early Prediction of Biliary Atresia Using Combi-Elastography in Infants ≤ 60 Days of Age
Background: To improve the early recognition of biliary atresia (BA) and timely treatment, this study developed a predictive model integrating combi-elastography, a novel form of elastography, to distinguish biliary atresia from other cholestatic liver diseases (non-BA) in infants. Method: A total of 69 children aged < 60 days with cholestatic hepatitis were retrospectively enrolled. All patients underwent conventional ultrasonography, combi-elastography, and laboratory testing. The variables were selected using logistic regression to construct a nomogram model, and the performance of the model was evaluated. Results: Multifactorial logistic regression analysis indicated that GGT (p = 0.015), the gallbladder morphology (p = 0.017), and the fibrosis index of the combi-elastography (p = 0.017) could be used as independent predictors to differentiate BA from other causes of cholestasis. A nomogram model constructed with these three indexes showed better performance, with an area under the operating characteristic curve (AUC) of 0.887 (0.823, 0.952) (p < 0.001), sensitivity of 86.4%, and specificity of 76.0%. Using 1000 Bootstrap resamples for internal validation of the model, the predictive effect of the nomogram model to identify biliary atresia from other cholestatic liver diseases was in good agreement with the actual situation. Decision-curve analysis showed that the use of the nomogram model to predict biliary atresia gained more clinical value at a risk threshold of 0.10–0.80. Conclusion: The nomogram constructed integrating combi-elastography and liver function indices shows promising value for predicting the risk for developing biliary atresia.
- 13 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (4) , 571
Open AccessEarly Prediction of Biliary Atresia Using Combi-Elastography in Infants ≤ 60 Days of Age
Background: To improve the early recognition of biliary atresia (BA) and timely treatment, this study developed a predictive model integrating combi-elastography, a novel form of elastography, to distinguish biliary atresia from other cholestatic liver diseases (non-BA) in infants. Method: A total of 69 children aged < 60 days with cholestatic hepatitis were retrospectively enrolled. All patients underwent conventional ultrasonography, combi-elastography, and laboratory testing. The variables were selected using logistic regression to construct a nomogram model, and the performance of the model was evaluated. Results: Multifactorial logistic regression analysis indicated that GGT (p = 0.015), the gallbladder morphology (p = 0.017), and the fibrosis index of the combi-elastography (p = 0.017) could be used as independent predictors to differentiate BA from other causes of cholestasis. A nomogram model constructed with these three indexes showed better performance, with an area under the operating characteristic curve (AUC) of 0.887 (0.823, 0.952) (p < 0.001), sensitivity of 86.4%, and specificity of 76.0%. Using 1000 Bootstrap resamples for internal validation of the model, the predictive effect of the nomogram model to identify biliary atresia from other cholestatic liver diseases was in good agreement with the actual situation. Decision-curve analysis showed that the use of the nomogram model to predict biliary atresia gained more clinical value at a risk threshold of 0.10–0.80. Conclusion: The nomogram constructed integrating combi-elastography and liver function indices shows promising value for predicting the risk for developing biliary atresia.
- Open Access
- 17 October 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (20) , 3229
Combi-Elasto Evaluation of the Degree of Liver Fibrosis in Children with Cholestatic Liver Disease
Cholestatic liver disease is a common liver disease in infants and young children. Liver fibrosis is a key factor affecting the prognosis, and liver transplantation is the only treatment option for liver cirrhosis. This study aimed to explore the efficacy of Combi-elasto for diagnosing liver fibrosis in children affected by cholestatic liver disease. A total of 64 children with S1–S4-grade liver fibrosis were enrolled. The general data, routine ultrasound, Combi-elasto, aspartate aminotransferase-to-platelet ratio index (APRI) and Fibrosis-4 (FIB-4) score were compared among children with different grades of liver fibrosis, and the efficacy of the above indexes for evaluating the degree of liver fibrosis was reported. There were remarkable differences in liver size, liver echogenicity, Young’s modulus (E), fibrosis index (FI), activity index (AI) and FIB-4 score among the groups (all p < 0.05). E and liver echogenicity were the independent impact factors of liver fibrosis. The areas under the curve of E, APRI, FIB-4 score and the combined model (E+ liver echogenicity) in the evaluation of liver fibrosis were 0.84, 0.61, 0.66 and 0.90, respectively. Ultimately, we concluded that CE is an effective method to evaluate liver fibrosis in children with cholestatic liver disease.
- 17 October 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (20) , 3229
Open AccessCombi-Elasto Evaluation of the Degree of Liver Fibrosis in Children with Cholestatic Liver Disease
Cholestatic liver disease is a common liver disease in infants and young children. Liver fibrosis is a key factor affecting the prognosis, and liver transplantation is the only treatment option for liver cirrhosis. This study aimed to explore the efficacy of Combi-elasto for diagnosing liver fibrosis in children affected by cholestatic liver disease. A total of 64 children with S1–S4-grade liver fibrosis were enrolled. The general data, routine ultrasound, Combi-elasto, aspartate aminotransferase-to-platelet ratio index (APRI) and Fibrosis-4 (FIB-4) score were compared among children with different grades of liver fibrosis, and the efficacy of the above indexes for evaluating the degree of liver fibrosis was reported. There were remarkable differences in liver size, liver echogenicity, Young’s modulus (E), fibrosis index (FI), activity index (AI) and FIB-4 score among the groups (all p < 0.05). E and liver echogenicity were the independent impact factors of liver fibrosis. The areas under the curve of E, APRI, FIB-4 score and the combined model (E+ liver echogenicity) in the evaluation of liver fibrosis were 0.84, 0.61, 0.66 and 0.90, respectively. Ultimately, we concluded that CE is an effective method to evaluate liver fibrosis in children with cholestatic liver disease.